TNGX — Tango Therapeutics Inc · $5.36B cap

Tango Therapeutics Inc (TNGX) is a biotechnology company listed on NASDAQ.

Latest reported TNGX revenue for 2026-06-30 was $0. Net income was -$100.9M. TNGX currently screens at market cap $5.36B.

Use this TNGX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TNGX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TNGX SEC filings page. Lician reads the product cache first so this HTML stays unique to Tango Therapeutics Inc even when a live quote feed is slow.

Tango Therapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full TNGX income, balance, and cash tables.

  • Revenue$62.4M
  • Net Income-$101.6M
  • Total Assets$398.7M
  • Total Debt$0
  • Free Cash Flow-$139.9M

TNGX recent filings